ProPhase Labs Inc (PRPH)
5.00
-0.06
(-1.19%)
USD |
NASDAQ |
Apr 25, 12:52
ProPhase Labs Cash from Operations (Quarterly): -0.213M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.213M |
| September 30, 2023 | -4.654M |
| June 30, 2023 | -6.957M |
| March 31, 2023 | 0.476M |
| December 31, 2022 | 0.811M |
| September 30, 2022 | 2.632M |
| June 30, 2022 | 4.821M |
| March 31, 2022 | 20.29M |
| December 31, 2021 | -4.647M |
| September 30, 2021 | -5.522M |
| June 30, 2021 | 4.442M |
| March 31, 2021 | -7.892M |
| December 31, 2020 | -6.768M |
| September 30, 2020 | -0.481M |
| June 30, 2020 | 4.372M |
| March 31, 2020 | 0.285M |
| December 31, 2019 | -0.428M |
| September 30, 2019 | -0.889M |
| June 30, 2019 | -0.927M |
| March 31, 2019 | 1.403M |
| December 31, 2018 | -0.781M |
| September 30, 2018 | -1.301M |
| June 30, 2018 | 0.129M |
| March 31, 2018 | -0.166M |
| December 31, 2017 | -1.726M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.445M |
| June 30, 2017 | -3.674M |
| March 31, 2017 | 3.007M |
| December 31, 2016 | 0.398M |
| September 30, 2016 | -0.682M |
| June 30, 2016 | -1.191M |
| March 31, 2016 | 1.003M |
| December 31, 2015 | -1.012M |
| September 30, 2015 | -3.215M |
| June 30, 2015 | -1.402M |
| March 31, 2015 | 2.132M |
| December 31, 2014 | -1.738M |
| September 30, 2014 | -2.442M |
| June 30, 2014 | -1.987M |
| March 31, 2014 | 2.951M |
| December 31, 2013 | 0.856M |
| September 30, 2013 | -3.26M |
| June 30, 2013 | -0.236M |
| March 31, 2013 | 3.777M |
| December 31, 2012 | -2.336M |
| September 30, 2012 | -2.694M |
| June 30, 2012 | -1.474M |
| March 31, 2012 | 0.775M |
| December 31, 2011 | 0.937M |
| September 30, 2011 | -3.594M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-7.892M
Minimum
Mar 2021
20.29M
Maximum
Mar 2022
-0.0659M
Average
-0.428M
Median
Dec 2019
Cash from Operations (Quarterly) Benchmarks
| Fonar Corp | 4.071M |
| XWELL Inc | -3.201M |
| Applied DNA Sciences Inc | -3.758M |
| Veracyte Inc | 15.55M |
| OncoCyte Corp | -4.562M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.264M |
| Cash from Financing (Quarterly) | 2.924M |
| Free Cash Flow | -14.50M |
| Free Cash Flow Per Share (Quarterly) | -0.0843 |
| Free Cash Flow to Equity (Quarterly) | -4.482M |
| Free Cash Flow to Firm (Quarterly) | -1.182M |
| Free Cash Flow Yield | -16.54% |